Lu Cha

Camellia sinensis (L.) O. Kuntze

Also known as: Green tea(English) 绿茶(Chinese)

Lu Ch'a

Updated October 5, 2026 · Not yet clinically reviewed

Lu Cha
Köhler's Medizinal-Pflanzen, 1897 · public domain, via Wikimedia Commons

Safety at a glance

Caution

4 recorded drug interactions, 1 major or contraindicated

No rule in our tables for this herb: pregnancy, breastfeeding, incompatible pairs (十八反 / 十九畏), herb–drug, dose ceiling. This is not a safety clearance.
Not graded —

No toxicity grade is recorded. Most herbs in the catalogue carry none.

Traditional Chinese Medicine

Category
clearing heat
Temperature
Cool
Taste
Bitter,Sweet
Channels
Heart,Lung,Stomach

Functions

Clears the Head and Brightens the Eyes; Eliminates Irritability and Relieves Thirst; Resolves Phlegm; Promotes Digestion and Resolves Food Stagnation; Promotes Urination; Resolves Toxicity

Traditional uses

Lu Cha (green tea) is a cool, bitter-sweet beverage-herb with a history of medicinal use in Chinese medicine spanning millennia. It clears internal Heat, relieves headaches and mental fogginess from Heat, aids digestion after rich meals, and quenches thirst. Modern research supports its antioxidant, cardiovascular, and metabolic benefits. It is best suited for those with robust constitutions and is used cautiously by those with cold or weak digestion, as its cold nature can weaken Spleen Yang with excessive consumption.

Western herbalism

Properties: antioxidant, stimulant, astringent

Formulas using this herb

5 of 5 formulas

Botanical

Camellia sinensis, the tea plant, is an evergreen shrub or small tree of the family Theaceae native to a broad region of southern China, northeastern India, Myanmar and northern Indochina, where it grows naturally as an understorey tree up to 10-15 m tall but is maintained at 1-1.5 m in cultivation by regular plucking. The alternate, leathery, elliptic to oblanceolate leaves are 4-15 cm long with finely serrate margins, dark glossy green above and lighter beneath, the young shoots silvery-pubescent. Solitary or paired axillary flowers about 2.5-4 cm across have five to seven white obovate petals surrounding numerous yellow stamens, and are followed by woody three-celled capsules containing one to three rounded brown seeds. For green tea (Lu Cha) the freshly plucked terminal shoots are heat-fixed (pan-fired or steamed) to inactivate polyphenol oxidase and then rolled and dried.

Pharmaceutical name
Folium Camelliae Sinensis
Parts used
leaf
Plant type
shrub

Constituents

(-)-Epigallocatechin-3-gallate (EGCG)

Flavan-3-ol (catechin) · The most abundant and pharmacologically important catechin, often 50–80% of the total catechin content of green tea

The signature green-tea polyphenol with potent antioxidant, anti-inflammatory and anticancer activity. It modulates drug-metabolising enzymes and transporters and is responsible for several documented herb–drug interactions.

Other catechins (EGC, ECG, EC, catechin)

Flavan-3-ols (catechins) · Together with EGCG make up the major polyphenol fraction of the leaf

Contribute the astringency and antioxidant capacity of green tea; support the traditional actions of clearing heat, relieving thirst and promoting digestion.

Caffeine

Purine (methylxanthine) alkaloid · Roughly 2–4% of the dry leaf

A CNS stimulant and mild diuretic underpinning the traditional functions of clearing the head, brightening the eyes, promoting urination and dispelling drowsiness.

L-Theanine

Non-protein amino acid · A characteristic free amino acid of tea leaves

Promotes relaxation without sedation and modulates the stimulant effect of caffeine, contributing to green tea's calming yet alertness-sharpening quality.

Flavonols (quercetin, kaempferol and glycosides)

Flavonol polyphenols · Minor polyphenol constituents

Antioxidant flavonoids adding to the radical-scavenging and vascular-protective properties of the infusion.

Gallic acid and theogallin

Phenolic acids · Present as free acids and catechin gallate esters

Antioxidant phenolics; gallic acid moieties on gallated catechins (EGCG, ECG) are key to transporter/enzyme interactions and to reduced non-heme iron absorption.

Vitamin K (phylloquinone)

Fat-soluble vitamin · Present in tea leaves; concentrated in the dried leaf and matcha

Relevant to the potential antagonism of vitamin-K-antagonist anticoagulants; large intakes of leaf material can reduce warfarin efficacy.

Drug interactions

Bortezomib (and other boronic-acid proteasome inhibitors)

Major · Antagonism — green tea polyphenols can abolish the drug's anticancer effect · Evidence level: Established

EGCG and other 1,2-benzenediol (catechol/pyrogallol) polyphenols react directly with the boronic-acid group of bortezomib, forming a boronate ester that inactivates its proteasome-inhibitory activity. This blocks bortezomib-induced ER stress and tumour-cell death in vitro and in vivo.

Clinical note: Patients on bortezomib (or MG-262/PS-IX-type boronic-acid inhibitors) should avoid green tea and EGCG supplements during treatment.

Nadolol (and other OATP1A2 substrate beta-blockers)

Moderate · Markedly reduced drug absorption and efficacy · Evidence level: Established

Green tea catechins inhibit the intestinal uptake transporter OATP1A2. In a controlled human study, green tea reduced nadolol Cmax and AUC by roughly 85% without changing renal clearance, attenuating its blood-pressure-lowering effect.

Clinical note: Separate green tea from nadolol dosing and monitor blood pressure; the interaction may extend to other OATP1A2-transported drugs.

Warfarin

Moderate · Reduced anticoagulant effect (case-report level) · Evidence level: Probable

Large volumes of green tea supply vitamin K, which can antagonise vitamin-K-antagonist anticoagulants and lower the INR; a classic case report described loss of anticoagulation with very high green-tea intake.

Clinical note: Keep green tea intake consistent and moderate; report large changes in consumption to the anticoagulation clinic and monitor INR.

Non-heme (dietary) iron

Moderate · Reduced iron absorption · Evidence level: Established

Tea tannins/gallated catechins chelate non-heme iron in the gut lumen and inhibit its absorption, which can worsen iron-deficiency when tea is taken with meals or iron supplements.

Clinical note: Take iron supplements and iron-rich meals at least 1–2 hours apart from green tea, especially in iron-deficiency anaemia.

Preparations

Infusion (steeped tea)

Parts used: Dried unfermented leaf and bud

Steep roughly 2–3 g of leaf in hot (70–85°C) water for a few minutes and drink as a beverage to clear heat, relieve thirst, refresh the head and promote digestion. Lower temperatures preserve catechins and reduce bitterness.

Matcha (whole-leaf powder)

Parts used: Powdered shade-grown leaf

Finely milled green-tea powder whisked into water so the whole leaf is consumed, giving higher catechin, caffeine and vitamin K intake per serving.

Standardized green tea extract

Parts used: Leaf (concentrated polyphenol extract)

Concentrated catechin/EGCG extracts used as supplements; because they deliver much higher polyphenol doses than brewed tea, they carry greater interaction and (rarely) hepatotoxicity risk and should be used cautiously.

Evidence

Study design on record, not certainty of outcome.

Randomized controlled trial
1
In vitro / animal
1

Green Tea Ingestion Greatly Reduces Plasma Concentrations of Nadolol in Healthy Subjects

Misaka S, Yatabe J, Müller F, et al. · Clinical Pharmacology & Therapeutics · 2014 · Randomized crossover pharmacokinetic study in healthy volunteers

Randomized controlled trial · Verified

Ten healthy subjects took 30 mg nadolol after 14 days of green tea (700 mL/day) or water. Green tea decreased nadolol Cmax and AUC0–48 by ~85% without altering renal clearance, and blunted its systolic-blood-pressure-lowering effect. Uptake assays identified nadolol as an OATP1A2 substrate, attributing the interaction to intestinal OATP1A2 inhibition by catechins.

doi:10.1038/clpt.2013.241

Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors

Golden EB, Lam PY, Kardosh A, et al. · Blood · 2009 · Preclinical in vitro and in vivo mechanistic study

In vitro / animal · Not yet verified

EGCG and related polyphenols with 1,2-benzenediol moieties prevented bortezomib-induced tumour-cell death in vitro and in vivo. EGCG reacted directly with bortezomib's boronic acid, blocking proteasome inhibition, ER stress and caspase-7 activation. The authors concluded green tea products may be contraindicated during bortezomib therapy.

doi:10.1182/blood-2008-07-171389

Cultural and historical

Cha Jing (The Classic of Tea), Lu Yu · Tang dynasty, c. 760 CE

The first monograph devoted to tea, describing its cultivation, preparation and its refreshing, mind-clearing effects.

Bencao Gangmu (Compendium of Materia Medica), Li Shizhen · Ming dynasty, 1578

Lists tea (cha/ming) among medicinals, noting its cooling nature and actions of clearing heat, resolving phlegm, aiding digestion and promoting urination.

Shennong Bencao Jing tradition · Han dynasty compilation (classical era)

Early materia medica lore credits tea with dispelling drowsiness, brightening the eyes and quenching thirst.

References

  1. Kyriacou C, et al.. Green Tea Catechins as Perpetrators of Drug Pharmacokinetic Interactions. Clinical Pharmacology & Therapeutics. 2025 doi:10.1002/cpt.3547
  2. Werba JP, Misaka S, Giroli MG, Shimomura K, Amato M, Simonelli N, Vigo L, Tremoli E. Update of green tea interactions with cardiovascular drugs and putative mechanisms. Journal of Food and Drug Analysis. 2018 doi:10.1016/j.jfda.2018.01.008
  3. Golden EB, Lam PY, Kardosh A, et al.. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood. 2009 doi:10.1182/blood-2008-07-171389
© Verscienta Health — use subject to the API terms at https://verscienta.com/developers/api; educational reference, not medical advice